NasdaqCM - Delayed Quote • USD
Cingulate Inc. (CING)
At close: April 26 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -1.29 | -0.83 | -3.21 | -3.24 |
| Low Estimate | -1.29 | -0.83 | -3.21 | -3.24 |
| High Estimate | -1.29 | -0.83 | -3.21 | -3.24 |
| Year Ago EPS | -7 | -11.4 | -26 | -3.21 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -6.8 | -7.07 | -7.4 | -4.86 |
| EPS Actual | -7 | -11.4 | -6 | -7.66 |
| Difference | -0.2 | -4.33 | 1.4 | -2.8 |
| Surprise % | -2.90% | -61.20% | 18.90% | -57.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -1.29 | -0.83 | -3.21 | -3.24 |
| 7 Days Ago | -1.29 | -0.83 | -3.21 | -3.24 |
| 30 Days Ago | -3.78 | -3.3 | -11.55 | 2.32 |
| 60 Days Ago | -3.78 | -3.3 | -11.55 | 2.32 |
| 90 Days Ago | -3.78 | -3.3 | -11.55 | 2.32 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CING | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 81.60% | -- | -- | 6.50% |
| Next Qtr. | 92.70% | -- | -- | 12.00% |
| Current Year | 87.70% | -- | -- | 5.30% |
| Next Year | -0.90% | -- | -- | 13.10% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/5/2024 |
| Downgrade | Laidlaw & Co.: Buy to Hold | 12/22/2023 |
| Downgrade | Maxim Group: Buy to Hold | 12/19/2023 |
| Downgrade | Maxim Group: Buy to Hold | 12/18/2023 |
Related Tickers
FWBI First Wave BioPharma, Inc.
2.7400
+0.37%
NEXI NexImmune, Inc.
3.3700
-1.17%
PBLA Panbela Therapeutics, Inc.
0.4100
-6.82%
TENX Tenax Therapeutics, Inc.
3.4800
-0.85%
ADTX Aditxt, Inc.
2.3900
-5.53%
THAR Tharimmune, Inc.
0.3691
+2.50%
CDIO Cardio Diagnostics Holdings, Inc.
0.6900
-4.49%
SPRC SciSparc Ltd.
1.3200
+4.76%
TARA Protara Therapeutics, Inc.
2.9250
-4.10%
NRBO NeuroBo Pharmaceuticals, Inc.
3.1400
+2.61%